Published in Nature Nanotechnology · View the paper (DOI)
Researchers develop world's first oral microbiome-based nanomedicine to enhance immune cells' ability to attack cancer cells. The new drug, Prodrug 201, significantly increases bioavailability and effectively directs stem-like T cells into tumor sites.
Coverage from 2 institutions